Apis Health Angels

Congratulations to the successful companies that brought their drugs to market.
Always interesting to read the annual summary.
Super positive reinforcement for the work that startups are doing….there is a goal post.

FDA Approved New Drugs in 2022 That Will Improve the Lives of Patients In 2022, CDER approved 37 new drugs never before approved or marketed in the U.S., known as “novel” drugs.

Happy New Year!

We look forward to our work together in the new year!

Can you hear yourself saying...."Am I angel investment ready?"
Our investors can help you to answer that.

In our progressive due diligence program the questions get harder the further you go.

Receive the investor pot, AND get investor champions.

Register your Health Startup Today.

All startups should be considering their reimbursement strategies.
This announcement may effect yours if you are going for Breakthrough Designation with the FDA and you thought it might include speedier coverage by CMS.

CMS Repeals MCIT/R&N Rule; Will Consider Other Coverage Pathways to Enhance Access to Innovative Medical Devices | CMS The Agency will explore evidence-based approaches that protect people with Medicare

What kind of a business model do you operate in?

Do you have any pressing questions on what would work best for your startup?

Harold Wodlinger has a lot of experience evaluating on Health Company Business Models.

John Sechrest
Seattle Angel Conference

Innovation in Health - Successful Business Models in Medtech As an investor, the choice of business model has a profound effect on the timing of an exit.

Discussions on cap table mechanics are sometimes awkward. They needn't be if you have the right tools for the discussion.
Join Seattle Angel Conference John Sechrest as he hosts GUST guests Peter and Ryan to talk about what you should be aware of.

Managing Early Startup Equity Thu, Nov 11, 2021, 12:00 PM: How you issue equity to your founding team and early service providers (advisors, contractors) sets the foundation for all future negotiations around ownership. Making sur

Last week one key item our Funders Panelists identified was the need for understanding how to use your intellectual property as a strategic and competitive advantage.

Ryan Buckmaster advises companies on this all the time.
He will be sharing his wisdom with us Thursday November 4th 5-7pm.

What question do you have about your IP?

Leveraging Intellectual Property Intellectual Property is an essential strategic factor. Learn how to make it so.

Welcome. Health is a $8.45 trillion industry and has the chance to significantly impact social well being. An angel investment in health/lifesciences supports developing startups and founders via funds, expertise and networking. Making a group angel investment increases knowledge and decreases risk, and provides the opportunity to network with like-minded investors and entrepreneurs. We offer workshops to build stronger investors and more investable companies.

Welcome! You are at the right place to learn more about angel investing in the $8.45 trillion health and life sciences industry. Angel Investors play a large role in supporting newly launched companies with funds, advice, and connections. A group group increases the expertise and decreases the risk of your investment (noting that all angel investing is risky).